Hendriksz, C. J., Harmatz, P., Giugliani, R., Roberts, J., & Arul, G. S. (2018). Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders. Mol Genet Metab Rep.
Chicago ZitierstilHendriksz, Christian J., Paul Harmatz, Roberto Giugliani, Jane Roberts, und G. Suren Arul. "Risks of Long-term Port Use in Enzyme Replacement Therapy for Lysosomal Storage Disorders." Mol Genet Metab Rep 2018.
MLA ZitierstilHendriksz, Christian J., et al. "Risks of Long-term Port Use in Enzyme Replacement Therapy for Lysosomal Storage Disorders." Mol Genet Metab Rep 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.